Peter Lichtlen
2014
In 2014, Peter Lichtlen earned a total compensation of $1.1M as Chief Medical Officer at Sucampo Pharmaceuticals, a 99% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $88,968 |
|---|---|
| Option Awards | $471,008 |
| Salary | $195,084 |
| Other | $355,302 |
| Total | $1,110,362 |
Lichtlen received $471K in option awards, accounting for 42% of the total pay in 2014.
Lichtlen also received $89K in non-equity incentive plan, $195.1K in salary and $355.3K in other compensation.
Rankings
In 2014, Peter Lichtlen's compensation ranked 7,119th out of 13,032 executives tracked by ExecPay. In other words, Lichtlen earned more than 45.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,119 out of 13,032 | 45th |
Division Manufacturing | 2,619 out of 4,965 | 47th |
Major group Chemicals And Allied Products | 893 out of 1,690 | 47th |
Industry group Drugs | 702 out of 1,369 | 49th |
Industry Pharmaceutical Preparations | 539 out of 1,042 | 48th |
Source: SEC filing on April 18, 2016.
Lichtlen's colleagues
We found five more compensation records of executives who worked with Peter Lichtlen at Sucampo Pharmaceuticals in 2014.
2014
Peter Greenleaf
Sucampo Pharmaceuticals
Chief Executive Officer
2014
Peter Kiener
Sucampo Pharmaceuticals
Chief Scientific Officer
2014
Matthias Alder
Sucampo Pharmaceuticals
General Counsel
2014
Max Donley
Sucampo Pharmaceuticals
EVP, Global Human Resources, Information Technology and Strategy
2014
Andrew Smith
Sucampo Pharmaceuticals